Valuation: Artivion, Inc.

Market Cap 1.14B 993M 937M 851M 1.59B 109B 1.6B 11.23B 4.33B 55.54B 4.28B 4.18B 179B P/E 2026 *
-66.7x
P/E 2027 * 88.1x
Enterprise Value 1.14B 993M 937M 851M 1.59B 109B 1.6B 11.23B 4.33B 55.54B 4.28B 4.18B 179B EV / Sales 2026 *
2.32x
EV / Sales 2027 * 2.1x
Free-Float
89.42%
Yield 2026 *
-
Yield 2027 * -
1 day-4.59%
1 week-1.89%
Current month-9.57%
1 month-16.13%
3 months+13.66%
6 months-34.49%
Current year-46.73%
1 week 20.8
Extreme 20.8
22
1 month 20.8
Extreme 20.8
23.8
Current year 17.4
Extreme 17.4
38.9
1 year 17.4
Extreme 17.4
41.1
3 years 11.7
Extreme 11.7
41.1
5 years 10.1
Extreme 10.1
41.1
10 years 10.1
Extreme 10.1
41.1
Manager TitleAgeSince
Chief Executive Officer 59 2014-09-01
Director of Finance/CFO 53 2023-12-03
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 71 2003-11-30
Director/Board Member 66 2003-11-30
Director/Board Member 61 2012-04-30
Change 5-day change 1-year change 3-year change Capi.($)
-4.59%-1.89% - - 1.14B
+0.37%+0.65%-24.57%+1.93% 178B
-0.69%+1.29%-3.10%+11.50% 118B
-0.20%-3.98%+6.47%+71.79% 58.92B
-0.24%+1.74%-3.26%-31.97% 49.29B
-0.22%-0.37%+10.27%+40.45% 48.17B
+1.61%+7.61%+32.47%-5.11% 33.72B
-1.49%-2.74% - - 27.76B
-1.17%+4.64%+42.17%-7.72% 25.5B
+1.02%+5.99%+6.51%-15.81% 22.1B
Average -0.56%+1.85%+8.37%+8.13% 62.32B
Weighted average by Cap. -0.09%+1.03%-3.19%+10.47%

Financials

2026 *2027 *
Net sales 490M 428M 404M 367M 687M 47.06B 690M 4.84B 1.87B 23.92B 1.84B 1.8B 76.98B 543M 474M 447M 406M 761M 52.12B 764M 5.36B 2.07B 26.5B 2.04B 2B 85.27B
Net income -16.53M -14.42M -13.61M -12.36M -23.16M -1.59B -23.26M -163M -62.93M -807M -62.11M -60.73M -2.6B 11.4M 9.94M 9.38M 8.52M 15.96M 1.09B 16.03M 112M 43.37M 556M 42.81M 41.85M 1.79B
Net Debt - -
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
1,800
Date Price Change
26-09-18 €20.80 -4.59%
26-09-17 €21.80 -0.91%
26-09-16 €22.00 +2.80%
26-09-15 €21.40 0.00%
26-09-14 €21.40 +0.94%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
23.35USD
Average target price
42.15USD
Spread / Average Target
+80.51%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!